SCHEMBL29385382

SCHEMBL29385382

COc1cc(OC)c(Cl)c(-c2ccc3nc(Cl)ncc3c2)c1Cl

nearest known ligand 0.69

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FGFR4 P22455 17/20 0.69
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
FGFR1 P11362 9/20 0.53
FGFR2 P21802 5/20 0.53
FGFR3 P22607 5/20 0.53
RPS6KB2 Q9UBS0 1/20 0.53
CYP1A2 P05177 1/20 0.48
CSF1R P07333 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15412791 1.00 FGFR4 (0.69) FGFR4KDM4EALDH1A1SMN1; SMN2FGFR1
SCHEMBL21154002 0.92 FGFR4 (0.60) FGFR4KDM4EALDH1A1SMN1; SMN2FGFR1
SCHEMBL21154059 0.90 FGFR4 (0.56) FGFR4KDM4EALDH1A1SMN1; SMN2FGFR1
SCHEMBL16683513 0.87 FGFR4 (0.67) FGFR4FGFR1FGFR2FGFR3RPS6KB2
SCHEMBL16676911 0.86 FGFR4 (0.66) FGFR4FGFR1FGFR2FGFR3RPS6KB2
SCHEMBL16674626 0.84 FGFR4 (0.63) FGFR4FGFR1FGFR2FGFR3RPS6KB2
SCHEMBL28495534 0.83 FGFR4 (0.62) FGFR4FGFR1FGFR2FGFR3RPS6KB2
SCHEMBL27746938 0.82 KDM4E (0.64) FGFR4KDM4EALDH1A1SMN1; SMN2
SCHEMBL21153635 0.82 FGFR4 (1.00) FGFR4FGFR1FGFR2FGFR3RPS6KB2
SCHEMBL21153921 0.81 FGFR4 (0.60) FGFR4FGFR1FGFR2FGFR3RPS6KB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114057700-B Crystal forms of fibroblast growth factor receptor inhibitor and preparation method thereof 药捷安康(南京)科技股份有限公司 2024-04-19 CN disclosed
CN-117510513-A Heterocyclic compounds having biological activity 首药控股(北京)股份有限公司 2024-02-06 CN disclosed
CN-114057700-A Crystal form of fibroblast growth factor receptor inhibitor and preparation method thereof 药捷安康(南京)科技股份有限公司 2022-02-18 CN disclosed
CN-110028491-B Fibroblast growth factor receptor inhibitors 缆图药品公司 2022-02-11 CN disclosed
WO-2022022735-A1 CRYSTAL FORM OF FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR AND PREPARATION METHOD THEREFOR 药捷安康(南京)科技股份有限公司 2022-02-03 WO disclosed